Chief Scientific Officer
Dr. Behlke directed R&D at IDT from 1995-2021. He is also a scientific co-founder of Dicerna Pharmaceuticals, in Boston. Before joining IDT, he was a Physician Postdoctoral Fellow of the Howard Hughes Medical Institute at the Whitehead Institute, MIT, and a Resident Physician in Internal Medicine at Brigham and Women’s Hospital. Dr. Behlke received his M.D/Ph.D. degrees from Washington University in 1988 and B.S. degree from MIT in 1981. Dr. Behlke is an inventor on over 65 issued US patents and is an author on over 150 scientific publications and book chapters. He is a recognized expert on oligonucleotide-based technologies.